Delivery Order SPE2DR25D3005-SPE2DR26FP7DU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Teriflunomide 14 mg tablets (28-count packaging) with a ceiling value of $9,160.13. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The order is scheduled for ultimate completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $6,529.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for Aubagio 14 mg tablets (30-count packages) on October 23, 2025, with completion scheduled for November 14, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,387.08 for Terlivaz 0.85 mg vials on July 24, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 4569617740 ORSERDU 345 mg tablets (30-count units) on September 28, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside competitive award leverages AmerisourceBergen's indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,445.57 to AmerisourceBergen Drug Corp for the supply of TREMFYA 200 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,954.56 for ORSERDU 345 mg tablets (30-count) on October 20, 2025, with completion scheduled for November 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,732.10 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count) with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,449.29 to AmerisourceBergen Drug Corp for pharmaceutical products and services. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of the same day, represents a non-competitive award under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,093.40 for 100 tablets of Imuran 50 mg on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7DUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $57,546.06 to AmerisourceBergen Drug Corp for the supply of Teriflunomide 14 mg tablets (30-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside provisions and is set for completion by November 14, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle that extends through December 2026 and serves as the primary pharmaceutical support mechanism for military healthcare systems worldwide. The IDC enables the company to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic areas to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As the largest pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill such federal requirements through competitive procurement processes involving firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.5k | 11/13/25 |